Czech National Bank raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 3.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,046 shares of the medical equipment provider’s stock after buying an additional 3,436 shares during the period. Czech National Bank’s holdings in Intuitive Surgical were worth $40,719,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in ISRG. Aaron Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after acquiring an additional 19 shares in the last quarter. Evergreen Capital Management LLC lifted its stake in shares of Intuitive Surgical by 0.5% during the first quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock worth $2,124,000 after purchasing an additional 20 shares in the last quarter. Rise Advisors LLC boosted its position in shares of Intuitive Surgical by 5.6% in the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after buying an additional 20 shares during the period. Pinnacle Bancorp Inc. boosted its position in shares of Intuitive Surgical by 4.1% in the second quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock worth $289,000 after buying an additional 21 shares during the period. Finally, Vertex Planning Partners LLC grew its stake in shares of Intuitive Surgical by 2.3% in the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after buying an additional 21 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.
Intuitive Surgical Trading Up 0.4%
Shares of NASDAQ:ISRG opened at $556.86 on Thursday. The firm has a market cap of $199.62 billion, a PE ratio of 73.66, a price-to-earnings-growth ratio of 5.10 and a beta of 1.68. The company has a fifty day simple moving average of $536.26 and a 200 day simple moving average of $505.77. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.
Insiders Place Their Bets
In other news, insider Gary S. Guthart sold 28,800 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the transaction, the insider owned 27,027 shares in the company, valued at approximately $14,798,904.12. This trade represents a 51.59% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction that occurred on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $193,595.79. This represents a 95.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 114,007 shares of company stock valued at $63,533,844. 0.70% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on ISRG shares. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Sanford C. Bernstein reissued an “outperform” rating and set a $685.00 target price on shares of Intuitive Surgical in a research report on Tuesday, October 21st. Robert W. Baird set a $655.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Piper Sandler lifted their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Finally, Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $609.83.
Read Our Latest Research Report on ISRG
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- Which Wall Street Analysts are the Most Accurate?
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- Investing In Automotive Stocks
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
